 MILWAUKEE, March 4, 2021 PRNewswire -- Ademi LLP is investigating Five Prime NASDAQ: FPRX for possible breaches of fiduciary duty and other violations of law in its transaction with Amgen. Click here to learn how to join the action: or... 